Differential Induction of Apoptosis by Virulent Mycobacterium tuberculosis in Resistant and Susceptible Murine Macrophages: Role of Nitric Oxide and Mycobacterial Products

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1352-1361

  Rojas, Mauricio ^a   Barrera, Luis F ^a   Puzo, Germain ^b   Garcia, Luis F ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; GUANIDINE DERIVATIVE; MONOCLONAL ANTIBODY; NITRIC OXIDE; NITROPRUSSIDE SODIUM; RECOMBINANT GAMMA INTERFERON; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; BONE MARROW CELL; C57BL MOUSE; CELL LINE; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; KINETICS; MACROPHAGE; MICROBIOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; PHAGOCYTOSIS; PHYSIOLOGY; VIRULENCE;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BONE MARROW CELLS; CELL LINE; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GUANIDINES; IMMUNITY, NATURAL; INTERFERON-GAMMA, RECOMBINANT; KINETICS; MACROPHAGES; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; NITROPRUSSIDE; PHAGOCYTOSIS; TUBERCULIN; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 0031203033     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Vermes, Y., and C. Haanen. 1994. Apoptosis and programmed cell death in health and disease. Adv. Clin. Chem. 31:177.
2. Orrenius, S. 1995. Apoptosis: molecular mechanisms and implications for human disease. J. Int. Med. 237:529.
3. Mangan, D. F., G. R. Welch, and S. M. Wahl. 1991. Lipopolysaccharide, tumor necrosis factor-α, and IL-1-β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J. Immunol. 146:1541.
4. Munn, D. H., A. Beall, D. Song, R. W. Wrenn, and D. C. Throckmorton. 1995. Activation-induced-apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon-γ. J. Exp. Med. 181:127.
5. Arai, T., K. Hiromatsu, H. Nishimura, Y. Kimura, N. Kobayashi, H. Ishida, Y. Nimura, and Y. Yoshikai. 1995. Endogenous interleukin-10 prevents apoptosis in macrophages during Salmonella infection. Biochem. Biophys. Res. Commun. 2313:600.
6. Albina, J. E., S. Cui, R. B. Mateo, and J. S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150:5080.
7. Meßmer, U. K., E. G. Lapetina, and B. Brüne. 1995. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C-and protein kinase A-activating compounds. Mol. Pharmacol. 47:757.
8. S. H. E. Kaufmann. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129.
9. Molloy, A., P. Laochumroonvorapong, and G. Kaplan. 1994. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J. Exp. Med. 180:1499.
10. Gan, H., G. W. Newman, and H. G. Remold. 1995. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium. J. Immunol. 155:1304.
11. Monak, D. M., B. Raupach, A. E. Hromokyj, and S. Falkow. 1996. Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc. Natl. Acad. Sci. USA. 93:9833.
12. Nathan, C. 1991. Modulation of the antimicrobial host immune response: mechanisms and modulation of macrophage activation. Behring Inst. Mitt. 88:200.
13. Chan, J., Y. Xing, R. S. Magliozoo, and B. R. Bloom. 1992. Killing of virulent M. tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111.
14. Martin, J. H. J., and S. W. Edwards. 1994. Interferon-γ enhances monocyte reactive oxygen intermediate production: absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production. Immunology 81:592.
15. Radzioch, D., T. Hudson, M. Boulé, L. Barrera, J. W. Urbance, L. Varesio, and E. Skamene. 1991. Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophages lines. J. Leukocyte Biol. 50:263.
16. Barrera, L. H., Y. Kramnik, E. Skameme, and D. Radzioch. 1994. Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-γ and infection with BCG. Immunology 82:457.
17. Skamene, E., P. Gros, A. Forget, P. Konshavn, C. St. Charles and B. A. Taylor. 1982. Genetic resistance to intracellular pathogens. Nature 297:506.
18. Blackwell, J. M., C. H. Barton, J. K. White, T. I. A. Roach, M-A. Shaw, S. H. Whitehead, B. A. Mock, S. Sarle, H. Williams, and A. M. Baker. 1994. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol. Lett. 43:99.
19. Vidal, S. M., D. Malo, K. Vogan, E. Skamene, and P. Gros. 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 73:469.
20. 2-terminal sequence of macrophage-expressed natural resistence protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain. J. Exp. Med. 179:1683.
21. Roach, T. I. A., D. Chatterjee, and J. M. Blackwell. 1994. Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect. Immun. 62:1176.
22. Venisse, A., J.-M Berjeand, P. Chanenand, M. Guilleron, and G. Puzo. 1993. Structural features of lipoarabinomannan from Mycobacterium bovis BCG. J. Biol. Chem. 268:12401.
23. Youmans, G. P. 1979. The morphology and metabolism of mycobacteria. Tuberculosis. W. B. Saunders, Philadelphia, pp. 8-45.
24. Crowle, A. J., J. A. Sbarbaro, F. N. Judson, G. S. Douvas, and M. H. May. 1984. Inhibition by streptomycin of tubercle bacilli within cultured human macrophages. Am. Rev. Respir. Dis. 130:839.
25. Rook, G. A., J. Stell, L. Fraher, S. Baker, R. Karmali, J. O'riordan, and J. Standford. 1986. Vitamin D3, γ-interferon, and control of proliferation of M. tuberculosis by human monocyles. Immunology 57:199.
26. Moncada, S., R. M. J. Palmer, and A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109.
27. Misko, T. P., W. M. Moore, G. A. Nickols, J. A. Corbett, R. G. Titon, M. L. McDaniel, J. R. Williamson, and M. G. Curie. 1993. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol. 233:119.
28. Duke, R. C., and J. J. Cohen. 1991. Morphological, biochemical and flow cytometric assays of apoptosis. In Current Protocols in Immunology, J. E., Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. Vol. 1, Ch. 3. John Wiley & Sons, New York. pp. 3.17.1-3.17.32.
29. Raveche, E. S., A. D. Steinberg, A. L. DeFranco, and J. H. Tjio. 1982. Cell cycle analysis of lymphocyte activation in normal and autoimmune strains. J. Immunol. 23:1219.
30. 15N]nitrate in biological fluids. Anal. Biochem. 126:131.
31. Ding, A., C. F. Nathan, J. Gray, R. Deynck, D. J. Stuerh, and S. Srimal. 1990. Macrophage deactivating factor and transforming growth factors-1 -2, and -3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145:940.
32. Gavrieli, Y., Y. Sherman, and Y. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119:216.
33. Corbett, J. A., R. G. Tilton, K. Chang, K. S. Hasan, Y. Ido, J. L. Wang, M. A. Sweerland, J. R. Lancaster, Jr., J. R. Williamson, and M. L. McDaniel. 1992. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular disfunction. Diabetes. 41:552.
34. Drapier, J. C., J. Wietzerbin, and J. B. Hibbs. 1988. Interferon-γ priming of mouse and human macrophages for induction of tumor necrosis factor production. Eur. J. Immunol. 18:1587.
35. Takashima, T., C. Ueta, Y. Tsuyugushi, and S. Kishimoto. 1990. Production of tumor necrosis factor-α by monocytes from patients with pulmonary tuberculosis. Infect. Immun. 58:3286.
36. Valone, S. E., E. A. Rich, R. S. Wallis, and J. J. Ellner. 1988. Expression of TNF in vitro by human mononuclear phagocytes stimulated with whole M. bovis BCG and mycobacterial antigens. Infect. Immun. 56:3313.
37. Moreno, C., J. Taverne, and A. Mehlert. 1989. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumor necrosis factor for human and murine macrophages. Clin. Exp. Immunol. 76:240.
38. Eigler, A., B. Sinha, and S. Endres, 1993. Nitric oxide-releasing agents enhance cytokine induced tumor necrosis factor synthesis in human mononuclear cells. Biochem. Biophy. Res. Commun. 196:494.
39. Salkowski, C. A., S. A. Barber, G. R. Detore, and S. N. Vogel. 1996. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes. J. Immunol. 156:3107.
40. Vidal, S. M., and P. Gros. 1994. Resistance to infection with intracellular parasites: identification of a candidate gene. News Physiol. Sci. 9:178.
41. Gly169 allele. Infect. Immun. 64:2923.
42. Cui, S., J. S. Reichner, R. B. Mateo, and J. E. Albina. 1994. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or independent mechanisms. Cancer Res. 54:2462.
43. Wink, D. A., K. S. Kasprzak, C. M. Maragos, R. K. Elespuru, M. Misra, T. M. Dunams, T. A. Cebula, W. H. Koch, A. W. Andrews, J. S. Allen, and L. K. Keefer. 1991. DNA-deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001.
44. Arroyo, P. L., V. Hatch-Pigott, H. F. Mower, and R. V. Cooney. 1992. Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutation Res. 281:193.
45. Nguyen, T., D. Brunson, C. L. Crespi, B. W. Penman, J. S. Wishnok, and S. R. Tannenbaum. 1992. DNA damage and mutation of human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA 89:3030.
46. Zhang, J., V. L. Dawson, T. M. Dawson, and S. H. Snyder. 1994. Nitric oxide activation of poly(ADP-ribose)-synthethase in neurotoxicity. Science 263:687.
47. Barr, P. J., and L. D. Tomei. 1994. Apoptosis and its role in human disease. Biotechnology 12:487.
48. Moncada, S., and E. A. Higgs. 1991. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Inv. 21:361.
49. Castedo, M., A. Machado, N. Zamzami, T. Hirsch, P. Marcheti, and G. Kroemer. 1995. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25:3277.
50. Castedo, M., T. Hirsch, S. A. Susin, N. Zamzami, P. Marchetti, A. Machado, and G. Kroemer, G. 1996. Sequential acquisition of mitochondrial and plasma membrane alteration during early lymphocyte apoptosis. J. Immunol. 157:512.
51. Sibley, L. D., S. W. Hunter, P. J. Brennan, and J. L. Krahenbuhl. 1988. Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect. Immun. 56:1232.
52. Dahl, K. E., H. Shiratsuchi, B. D. Hamilton, J. J. Ellner, and Z. Tossii. 1996. Selective induction of transforming growth factor-β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect. Immun. 64:399.
53. Warwick-Davies, J., D. B. Lowrie, and P. J. Cole. 1995. Selective deactivation of human monocyte function by TGF-β. J. Immunol. 155:3186.
54. Vodovotz, Y., C. Bogdan, J. Paik, Q. Xie, and C. Nathan. 1993. Mechanism of suppression of macrophage nitric oxide release by transforming growth factor-β. J. Exp. Med. 178:605.
55. Vella, A. T., J. E. McCormack, P. S. Linsley, J. W. Kappler, and P. Marrack. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261.
56. Pugin, J., D. Heumann, A. Tomasz, V. V. Kravchnko, Y. Akamatsu, M. Nishijima. M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 its pattern recognition receptor. Immunity 1:509.
57. Tartaglia, L. A., R. F. Weber, I. S. Figari, C. Reynolds, M. A. Palladino, and D. V. Goedel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88:9292.
58. Leist, M., F. Ganter, S. Jilg, and A. Wendel. 1995. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154:1307.
59. Boldin, M. P., E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Fas/ APO1 contains a sequence motif related to death domain. J. Biol. Chem. 270:7795.
60. Pie, S., P. M. Beranard, O. T. Bachi, and C. Nauciel. 1996. Gamma interferon and interleukin-10 gene expression in innately susceptible and resistant mice during early phase of Salmonella typhimurium infection. Infect. Immun. 64:849.
61. Squier, M. K. T., A. J. Sehnert, and J. J. Cohen. 1995. Apoptosis in leukocytes. J. Leukocyte. Biol. 57:2.
62. Keane, J., M. K. Balcewicz-Sablinska, H. E. Remold, G. L. Chupp, B. B. Meek, M. J. Fenton and H. Kornfeld. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65:298.